Automated Detection of Kaposi Sarcoma-Associated Herpesvirus-Infected Cells in Immunohistochemical Images of Skin Biopsies
- PMID: 40239145
- PMCID: PMC12137223
- DOI: 10.1200/GO-24-00536
Automated Detection of Kaposi Sarcoma-Associated Herpesvirus-Infected Cells in Immunohistochemical Images of Skin Biopsies
Abstract
Purpose: Immunohistochemical staining for the antigen of Kaposi sarcoma (KS)-associated herpesvirus, latency-associated nuclear antigen (LANA), is helpful in diagnosing KS. A challenge lies in distinguishing anti-LANA-positive cells from morphologically similar brown counterparts. This work aims to develop an automated framework for localization and quantification of LANA positivity in whole-slide images (WSI) of skin biopsies.
Methods: The proposed framework leverages weakly supervised multiple-instance learning (MIL) to reduce false-positive predictions. A novel morphology-based slide aggregation method is introduced to improve accuracy. The framework generates interpretable heatmaps for cell localization and provides quantitative values for the percentage of positive tiles. The framework was trained and tested with a KS pathology data set prepared from skin biopsies of KS-suspected patients in Uganda.
Results: The developed MIL framework achieved an area under the receiver operating characteristic curve of 0.99, with a sensitivity of 98.15% and specificity of 96.00% in predicting anti-LANA-positive WSIs in a test data set.
Conclusion: The framework shows promise for the automated detection of LANA in skin biopsies, offering a reliable and accurate tool for identifying anti-LANA-positive cells. This method may be especially impactful in resource-limited areas that lack trained pathologists, potentially improving diagnostic capabilities in settings with limited access to expert analysis.
Conflict of interest statement
AUTHORS’ DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).
No other potential conflicts of interest were reported.
Update of
-
Automated detection of Kaposi sarcoma-associated herpesvirus infected cells in immunohistochemical images of skin biopsies.Res Sq [Preprint]. 2024 Aug 17:rs.3.rs-4736178. doi: 10.21203/rs.3.rs-4736178/v1. Res Sq. 2024. Update in: JCO Glob Oncol. 2025 Apr;11:e2400536. doi: 10.1200/GO-24-00536. PMID: 39184072 Free PMC article. Updated. Preprint.
Similar articles
-
Automated detection of Kaposi sarcoma-associated herpesvirus infected cells in immunohistochemical images of skin biopsies.Res Sq [Preprint]. 2024 Aug 17:rs.3.rs-4736178. doi: 10.21203/rs.3.rs-4736178/v1. Res Sq. 2024. Update in: JCO Glob Oncol. 2025 Apr;11:e2400536. doi: 10.1200/GO-24-00536. PMID: 39184072 Free PMC article. Updated. Preprint.
-
A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseases.Br J Dermatol. 2024 Jul 16;191(2):261-266. doi: 10.1093/bjd/ljae142. Br J Dermatol. 2024. PMID: 38581445
-
Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.mBio. 2018 May 8;9(3):e00756-18. doi: 10.1128/mBio.00756-18. mBio. 2018. PMID: 29739902 Free PMC article.
-
Treatment of Kaposi's sarcoma in HIV-1 infected individuals with emphasis on resource poor settings.Cochrane Database Syst Rev. 2003;(3):CD003256. doi: 10.1002/14651858.CD003256. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2014 Aug 13;(8):CD003256. doi: 10.1002/14651858.CD003256.pub2. PMID: 12917957 Updated.
-
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912. Health Technol Assess. 2024. PMID: 39186036 Free PMC article.
Cited by
-
Emerging Trends in Point-of-Care Technology Development for Oncology in Low- and Middle-Income Countries.JCO Glob Oncol. 2025 Jun;11:e2500142. doi: 10.1200/GO-25-00142. Epub 2025 Jun 18. JCO Glob Oncol. 2025. PMID: 40532137 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical